Wedbush Maintains Neutral on Gossamer Bio, Lowers Price Target to $32

Benzinga · 2d ago
Wedbush analyst Laura Chico maintains Gossamer Bio (NASDAQ:GOSS) with a Neutral and lowers the price target from $80 to $32.